These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2887782)

  • 1. Oral anticoagulant control.
    Lancet; 1987 Aug; 2(8557):488-9. PubMed ID: 2887782
    [No Abstract]   [Full Text] [Related]  

  • 2. Oral anticoagulant drugs.
    Ansell JE
    N Engl J Med; 1992 Jan; 326(1):68; author reply 68-9. PubMed ID: 1727070
    [No Abstract]   [Full Text] [Related]  

  • 3. Laboratory monitoring of oral anticoagulant therapy.
    Ginsberg JS; Hirsh J
    Hematol Pathol; 1989; 3(4):147-51. PubMed ID: 2697715
    [No Abstract]   [Full Text] [Related]  

  • 4. Problems of the laboratory control of oral anticoagulant treatment.
    Hummel L
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(4):529-31. PubMed ID: 2465967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of oral anticoagulant therapy.
    Biemer JJ
    Ann Clin Lab Sci; 1988; 18(6):421-8. PubMed ID: 3239946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological properties of the thromboplastins and plasmas included in the ICTH/ICSH collaborative study on prothrombin time standardization.
    Loeliger EA; van Halem-Visser LP
    Thromb Haemost; 1979 Dec; 42(4):1115-27. PubMed ID: 542924
    [No Abstract]   [Full Text] [Related]  

  • 7. Laboratory monitoring of oral anticoagulant therapy: are we being misled?
    Albers GW
    Neurology; 1993 Mar; 43(3 Pt 1):468-70. PubMed ID: 8450985
    [No Abstract]   [Full Text] [Related]  

  • 8. Intensity of oral anticoagulation, continued.
    N Engl J Med; 1983 Sep; 309(13):794-5. PubMed ID: 6888459
    [No Abstract]   [Full Text] [Related]  

  • 9. [External quality control and standardization of prothrombin time determination for the monitoring of oral anticoagulant treatment in the Netherlands].
    van Duuk-Wierda CA; Loeliger EA; Roos J
    Ned Tijdschr Geneeskd; 1980 Jan; 124(4):103-7. PubMed ID: 7374832
    [No Abstract]   [Full Text] [Related]  

  • 10. [Home use of an ambulatory monitor for the determination of prothrombin time (coaguchek) in patients treated with oral anticoagulants. Multicenter prospective study].
    Cosmi B; Palareti G; Moia M; Pengo V; Testa S
    Minerva Cardioangiol; 1999 Dec; 47(12):598-9. PubMed ID: 10670221
    [No Abstract]   [Full Text] [Related]  

  • 11. Rabbit (to replace human) brain material in anticoagulant control.
    Allington MJ; Bolton FG
    Lancet; 1986 May; 1(8489):1088. PubMed ID: 2871349
    [No Abstract]   [Full Text] [Related]  

  • 12. [Monitoring of patients treated with oral anticoagulants at a rural clinic].
    Labarta Mancho J; de los Ríos Roda C; Pérez Trullén JM
    Aten Primaria; 1997 Nov; 20(8):457. PubMed ID: 9462946
    [No Abstract]   [Full Text] [Related]  

  • 13. Anticoagulant monitoring of volunteers using prothrombin activity tests with abnormal control plasmas: a cooperative study.
    Lorberbaum H
    Am J Clin Pathol; 1971 Oct; 56(4):487-92. PubMed ID: 5113402
    [No Abstract]   [Full Text] [Related]  

  • 14. Management of oral anticoagulant treatment in patients with venous thromboembolism.
    Pengo V
    Semin Thromb Hemost; 2006 Nov; 32(8):781-6. PubMed ID: 17171590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ICSH/ICTH recommendations for reporting prothrombin time in oral anticoagulant control.
    Haematologica; 1985; 70(3):269-70. PubMed ID: 3932161
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prevention of venous thromboses with oral anticoagulants].
    Hach-Wunderle V; Scharrer I
    Wien Med Wochenschr; 1989 Dec; 139(23):559-62. PubMed ID: 2696215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Oral anticoagulant administration].
    Kiyose K; Fujita Y; Yamada T; Sakauchi H; Naka T
    Rinsho Byori; 1974 Oct; 22(10 Suppl):113. PubMed ID: 4475723
    [No Abstract]   [Full Text] [Related]  

  • 18. Spectrophotometric assays of prothrombin in plasma of patients using oral anticoagulants.
    Bertina RM; van der Marel-van Nieuwkoop W; Loeliger EA
    Thromb Haemost; 1979 Dec; 42(4):1296-305. PubMed ID: 542935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Confusion over the therapeutic range for monitoring oral anticoagulant therapy in North America.
    Hirsh J; Levine M
    Thromb Haemost; 1988 Apr; 59(2):129-32. PubMed ID: 3291180
    [No Abstract]   [Full Text] [Related]  

  • 20. [Influence of the protein induced by vitamin K absence on thrombotest and hepaplastintest in the patients treated with oral anticoagulant].
    Murakami S; Muratani H; Kikuchi T; Fujimoto S; Hayashi T; Inai S; Imaoka S
    Rinsho Byori; 1983 Jan; 31(1):105-9. PubMed ID: 6865023
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.